Brief: Kuros Biosciences Receives FDA 510(K) Clearance
Dec 10 (Reuters) - Kuros Biosciences AG KURN.S :
* RECEIVES FDA 510(K) CLEARANCE FOR EXTENDING COMMERCIAL
INDICATIONS OF MAGNETOS PUTTY IN UNITED STATES
Source text for Eikon: ID:nTENg2ptoa
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million